ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 82.47% of SKYE shares are held by financial institutions. MAI CAPITAL MANAGEMENT is the top corporate investor, holding 11.9K shares valued at $253.00. A 0% stake in Skye Bioscience, Inc. is owned by the company. owns - shares valued at -, which translates its holding of N/A of the stake in the company.
Among the SKYE insiders holding of 1.29% of the stake in company, HEPPELL JAMES L, director, holds the largest shares of 500K. DHILLON PUNIT, Chief Executive Officer, is the second largest SKYE insider with ownership of 329.82K shares. GRAYSON PAUL A., director, stands third with possession of 259.7K shares of that stake.